YilmazSAkbogaMKTopalogluS. Predictors of in-stent restenosis in patients with stable angina pectoris. Angiology. 2017;68:831.
2.
KundiHKorkmazABalunA. Is in-stent restenosis after a successful coronary stent implantation due to stable angina associated with TG/HDL-C ratio?Angiology. 2017;68:816–822.
3.
FerranteGNiccoliGBiasucciLM. Association between C-reactive protein and angiographic restenosis after bare metal stents: an updated and comprehensive meta-analysis of 2747 patients. Cardiovasc Revasc Med. 2008;9(3):156–165.
4.
BolcaOGüngörBÖzcanKS. The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI. Coron Artery Dis. 2015;26(5):402–408.
5.
YilmazSSenFÜnalS. Usefulness of the platelet-to-lymphocyte ratio in predicting bare-metal stent restenosis. Scand Cardiovasc J. 2015;49(1):39–44.
6.
YilmazSAkbogaMKSenF. Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis. Biomark Med. 2016;10(9):959–966.
7.
CelikIEYarliogluesMKurtulA. Preprocedural albumin levels and risk of in-stent restenosis after coronary stenting with bare-metal stent. Angiology. 2016;67(5):478–483.
8.
VegaGLBarlowCEGrundySM. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men. J Investig Med. 2014;62:345-349.
